2022 annual financial data
XORTX Therapeutics 2022 Financial results
Direct answer
Revenue was 0 CAD.
Operating income was -12,433,624 CAD and net income was -6,988,880 CAD.
Operating cash flow was -8,165,959 CAD.
Get free XORTX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -12,433,624 CAD
- Net income
- -6,988,880 CAD
- Operating cash flow
- -8,165,959 CAD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all XORTX Therapeutics financial years